Perelel Secures $27 Million Investment From Prelude Growth Partners

Women’s health company Perelel has secured a $27 million investment from Prelude Growth Partners with participation from existing investors Unilever Ventures, Willow Growth Partners and Selva Ventures.

Perelel, founded by Victoria Thain Gioia, Alex Taylor and practicing OB-GYN Banafsheh Bayati, launched in 2020 with doctor-developed formulas for prenatal support. Since its inception, Perelel has expanded beyond pregnancy and now includes solutions for a variety of need states, such as cycle support, postpartum, menopause, perimenopause, pre-conception and more. It is available direct-to-consumer, on Amazon and at Erewhon. The team declined to comment on specific sales figures but said the company is profitable and has more than doubled its revenue each year since launch.

With this raise, Perelel will continue to expand its assortment in women’s health to address all ages and stages, as well as double down on its commitment to clinical validation.

“We’ve been anchored in the motherhood journey, and that’s still our core,” said Thain Gioia. “We want to create products for women throughout their entire life cycle. We’ve been able to start that this year with our Triple-Support Protein.”

In the way of scientific validation, Thain Gioia said “the goal is to have a clinical that bolsters every product.” To date, Perelel has conducted clinicals on several of its formulas, including its Women’s Daily Vitamin Trio, $47, and Hormone Balance Support, $55.

Through the deal, Prelude replaces early angel investors, per the Perelel team.

With this deal, Prelude Growth Partners is expanding its stake in the growing wellness space, as the category continues to merge with beauty. Prior to this round, Prelude also invested in longevity-centric skin care brand OneSkin, clean home care brand Blueland and functional beverage brand So Good So You. The firm has also invested in a number of fast-growing beauty brands, including Sol de Janeiro and Tower28.

This deal also highlights the significance of the women’s health market, which continues to grow as new brands launch and retailers invest more heavily in the category.

“[When] we went to fundraise in April 2020… people didn’t understand this as a category and didn’t see it as a big opportunity,” said Thain Gioia. “There’s more conversation 1763674074, but we still need to see more research, more clinical backing, more brands not just saying the buzz word, but doing the work behind it… There’s a huge opportunity to continue to support women with these specific solutions that have clinical evidence and are made for exactly what she’s going through.”